Home | Molecular Cancer Research

October 2019
Read the October issue!
CRISPR Editing of Mutant IDH1 R132H Induces a CpG Methylation-Low State in Patient-Derived Glioma Models of G-CIMP
Casey J. Moure, et al.
Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination
Satoshi Washino, et al.
Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition
Teena Dhir, et al.
Enhanced Activity of Variant DNA Polymerase β (D160G) Contributes to Cisplatin Therapy by Impeding the Efficiency of NER
Meina Wang, et al.

From the Current Issue

Cancer Genes and Networks

AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast Cancers

Claire Tolza, Fabienne Bejjani, Emilie Evanno, Samantha Mahfoud, Gabriel Moquet-Torcy, Thierry Gostan, Muhammad Ahmad Maqbool, Olivier Kirsh, Marc Piechaczyk and Isabelle Jariel-Encontre

Mol Cancer Res October 1 2019 17 (10) 1999-2014; DOI:10.1158/1541-7786.MCR-19-0036
Cancer “-omics”

BORIS Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through GALNT14

Joanna C. Hillman, Elena M. Pugacheva, Carter J. Barger, Sirinapa Sribenja, Spencer Rosario, Mustafa Albahrani, Alexander M. Truskinovsky, Aimee Stablewski, Song Liu, Dmitri I. Loukinov, Gabriel E. Zentner, Victor V. Lobanenkov, Adam R. Karpf and Michael J. Higgins

Mol Cancer Res October 1 2019 17 (10) 2051-2062; DOI:10.1158/1541-7786.MCR-19-0310
Cancer “-omics”

The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models

Jorge Gómez-Miragaya, Sebastián Morán, Maria Eréndira Calleja-Cervantes, Alejandro Collado-Sole, Laia Paré, Antonio Gómez, Violeta Serra, Lacey E. Dobrolecki, Michael T. Lewis, Angel Diaz-Lagares, Pilar Eroles, Aleix Prat, Manel Esteller and Eva González-Suárez

Mol Cancer Res October 1 2019 17 (10) 2063-2076; DOI:10.1158/1541-7786.MCR-19-0040
Metabolism

Pharmacologic Ascorbate Primes Pancreatic Cancer Cells for Death by Rewiring Cellular Energetics and Inducing DNA Damage

Visarut Buranasudja, Claire M. Doskey, Adrienne R. Gibson, Brett A. Wagner, Juan Du, David J. Gordon, Stacia L. Koppenhafer, Joseph J. Cullen and Garry R. Buettner

Mol Cancer Res October 1 2019 17 (10) 2102-2114; DOI:10.1158/1541-7786.MCR-19-0381

See the Table of Contents

Recent Reviews

Review | AuthorChoice

The Emerging Role of YAP/TAZ in Tumor Immunity

Zhaoji Pan, Yiqing Tian, Chengsong Cao and Guoping Niu

Mol Cancer Res September 1 2019 17 (9) 1777-1786; DOI:10.1158/1541-7786.MCR-19-0375
Review

Insulinoma-Associated-1: From Neuroendocrine Tumor Marker to Cancer Therapeutics

Chiachen Chen, Abner L. Notkins and Michael S. Lan

Mol Cancer Res August 1 2019 17 (8) 1597-1604; DOI:10.1158/1541-7786.MCR-19-0286
Review

Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside

Justin Korfhage and David B. Lombard

Mol Cancer Res July 1 2019 17 (7) 1417-1428; DOI:10.1158/1541-7786.MCR-19-0147
Review

Mitotic Gene Bookmarking: An Epigenetic Program to Maintain Normal and Cancer Phenotypes

Sayyed K. Zaidi, Jeffrey A. Nickerson, Anthony N. Imbalzano, Jane B. Lian, Janet L. Stein and Gary S. Stein

Mol Cancer Res November 1 2018 16 (11) 1617-1624; DOI:10.1158/1541-7786.MCR-18-0415

Main menu

User menu

Search

From the Current Issue

Recent Reviews

OnlineFirst Articles

Articles

Information for

About MCR